Product Name: DRAK1 antibody [N1C1-2]
Applications: IHC-P, WB
Predicted Target Size: 47 kDa (note) (2)
Positive Controls: 293T , A431 , H1299 , HeLaS3 , HepG2 , Molt-4 , Raji
Form Supplied: Liquid
Concentration: 1.03 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Purified by antigen-affinity chromatography.
Full Name: serine/threonine kinase 17a
Background: This gene is a member of the DAP kinase-related apoptosis-inducing protein kinase family and encodes an autophosphorylated nuclear protein with a protein kinase domain. The protein has apoptosis-inducing activity. [provided by RefSeq]
Synonyms: DRAK1 antibody, STK17A antibody, serine/threonine-protein kinase 17A antibody, serine/threonine kinase 17a (apoptosis-inducing) antibody, DAP kinase-related apoptosis-inducing protein kinase 1 antibody, death-associated protein kinase-related 1 antibody, serine/threonine kinase 17a antibody
Cellular Localization: Nucleus
CAS NO: 941678-49-5
Product: Cinaciguat
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Recombinant protein encompassing a sequence within the center region of human DRAK1. The exact sequence is proprietary.
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: 0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Storage Instruction: Keep as concentrated solution. Aliquot and store at -20ÂșC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/16176945?dopt=Abstract
